Than Again biogenerics legislation is all about savings and i can see democrats and Obama pushing it so they can factor in future savings in spending models.
I could've sworn that a bio/pharma jb loss tracker thread was started, but i can't seem to find it. Can someone repost? It would be interesting to have everyone keep it updated to see how job losses correlate to clinical data, reg milestones, corp earnings, etc. It was apparent that the cuts were coming, but the domino speed is surprising me. Can't see anything but accelerating cuts for the next 3 quarters.
Market Data 
Markets 
AI
